Joerg Holenz is an accomplished pharmaceutical executive with extensive experience in research and development, particularly in neuroscience and pain management. Currently serving as the Chief Scientific Officer and Head of Research and Development at BIAL since November 2021, Joerg is also a Board Member at BIAL Biotech. Previously held positions include Senior Vice President at Grünenthal Group, where Joerg reorganized the R&D function, and Senior Director at GSK, where Joerg led a virtual Discovery Performance Unit focused on CNS treatments. Joerg's earlier roles at AstraZeneca included Director of Discovery and Preclinical Sciences, delivering leading first-in-class Alzheimer’s treatments, and positions in lead optimization and medicinal chemistry. Joerg began a career in academia with a Ph.D. in Organic and Medicinal Chemistry from The Julius Maximilians University of Würzburg and has contributed significantly to the development of novel therapies throughout a distinguished career spanning multiple leading pharmaceutical companies.
Org chart
Teams
This person is not in any teams
Offices
This person is not in any offices
BIAL
Founded in 1924, BIAL’s mission is to discover, develop and provide new therapeutic solutions within the area of Health. Today, BIAL is an innovative international pharmaceutical company with products available in more than 50 countries. The company is committed to making a contribution to improve human health and quality of life for people from all over the world. Its strategic areas are Innovation, Internationalisation and Quality. Strongly committed to therapeutic innovation, and consistently investing more than 20% of its annual revenue in Research and Development (R&D), BIAL has established an ambitious R&D programme. The key focus area for the Group is neurosciences. The company headquarters are located in Portugal. BIAL has also facilities in Spain, Germany, United Kingdom, Italy, Switzerland, US, Mozambique, Angola, Panama and Ivory Coast. BIAL Group is a member of the “European Federation of Pharmaceutical Industries and Associations” (EFPIA). BIAL has also been distinguished by its support to several medical and scientific activities, namely through BIAL Foundation, having as outstanding events the BIAL Award in Biomedicine, the Prémio BIAL de Medicina Clínica and Scientific Research Grants, well recognized worldwide. For more information, please visit: www.bial.com For issues of safety or others related to product quality, please contact: pharmacovigilance@bial.com
